Provectus Biopharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This assessment of Provectus Biopharmaceuticals Inc incorporates information from across the internet and also from available filings by Provectus Biopharmaceuticals Inc. Jump to the bottom of the page for potential risks for Provectus Biopharmaceuticals Inc based on industry, location and size. The ESG rating includes 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Provectus Biopharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 5.3, social score of 6.4 and governance score of 4.0.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 912 | Vivanza Biosciences Ltd | 5.3 | High |
| 912 | ValiRx PLC | 5.3 | High |
| 958 | Provectus Biopharmaceuticals Inc | 5.2 | High |
| 958 | Altimmune Inc | 5.2 | High |
| 958 | Agios Pharmaceuticals Inc | 5.2 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Provectus Biopharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Provectus Biopharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Provectus Biopharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Provectus Biopharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Provectus Biopharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Provectus Biopharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Provectus Biopharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver; uveal melanoma metastatic to the liver; and pediatric solid tumor cancers, such as neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma. The company is also developing oral formulations of current good manufacturing practice rose bengal sodium (cGMP RBS) for the treatment of adult solid tumor cancers, such as head and neck, breast, testicular, and colorectal cancers; pediatric blood cancers, including leukemia; coronavirus, an acute respiratory syndrome; multi-drug resistant bacteria, such as gram-negative bacteria; and for eye diseases, including infectious keratitis. In addition, it develops PH-10, an investigational immuno-dermatology agent for the treatment of inflammatory dermatoses, such as psoriasis and atopic dermatitis. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee.